• Ahlke, E., Nowak-Göttl, U., Schulze-Westhoff, P., Werber, G., Borste, H., Wurthwein, G., Jürgens, H. & Boos, J. (1997) Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia. British Journal of Haematology, 96, 675681.
  • Albertsen, B.K., Schroder, H., Jakobsen, P., Muller, H.J., Carlsen, N.T. & Schmiegelow, K. (2001) Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. British Journal of Clinical Pharmacology, 52, 433437.
  • An, Q., Wright, S.L., Konn, Z.J., Matheson, E., Minto, L., Moorman, A.V., Parker, H., Griffiths, M., Ross, F.M., Davies, T., Hall, A.G., Harrison, C.J., Irving, J.A. & Strefford, J.C. (2008) Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proceedings of the National Academy of Sciences of the United States of America, 105, 1705017054.
  • An, Q., Wright, S.L., Moorman, A.V., Parker, H., Griffiths, M., Ross, F.M., Davies, T., Harrison, C.J. & Strefford, J.C. (2009) Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21. Haematologica, 94, 11641169.
  • Attarbaschi, A., Mann, G., Dworzak, M., Urban, C., Fink, F.M., Dieckmann, K., Riehm, H. & Gadner, H. (2002) Treatment results of childhood acute lymphoblastic leukemia in Austria – a report of 20 years’ experience. Wiener Klinische Wochenschrift, 114, 148157.
  • Attarbaschi, A., Mann, G., Panzer-Grümayer, R., Röttgers, S., Steiner, M., König, M., Csinady, E., Dworzak, M.N., Seidel, M., Janousek, D., Möricke, A., Reichelt, C., Harbott, J., Schrappe, M., Gadner, H. & Haas, O.A. (2008) Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Journal of Clinical Oncology, 26, 30463050.
  • Clark, R., Byatt, S.A., Bennett, C.F., Brama, M., Martineau, M., Moorman, A.V., Roberts, K., Secker-Walker, L.M., Richards, S., Eden, O.B., Goldstone, A.H. & Harrison, C.J. (2000) Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia, 14, 241246.
  • Van Der Does-van den Berg, A., Bartram, C.R., Basso, G., Benoit, Y.C., Biondi, A., Debatin, K.M., Haas, O.A., Harbott, J., Kamps, W.A., Koller, U., Lampert, F., Ludwig, W.D., Niemeyer, C.M. & Van Wering, E.R. (1992) Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” Cooperative Group. Medical and Pediatric Oncology, 20, 497505.
  • Van Dongen, J.J., Seriu, T., Panzer-Grümayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., Van Wering, E.R., Ludwig, W.D., Basso, G., De Bruijn, M.A., Cazzaniga, G., Hettinger, K., Van Der Does-van den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 17311738.
  • Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grümayer, R., Van Der Velden, V., Fischer, S., Stanulla, M., Basso, G., Niggli, F.K., Schafer, B.W., Sutton, R., Koehler, R., Zimmermann, M., Valsecchi, M.G., Gadner, H., Masera, G., Schrappe, M., Van Dongen, J.J., Biondi, A. & Bartram, C.R. (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22, 771782.
  • Forestier, E., Gauffin, F., Andersen, M.K., Autio, K., Borgstrom, G., Golovleva, I., Gustafsson, B., Heim, S., Heinonen, K., Heyman, M., Hovland, R., Johannsson, J.H., Kerndrup, G., Rosenquist, R., Schoumans, J., Swolin, B., Johansson, B. & Nordgren, A. (2008) Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes, Chromosomes and Cancer, 47, 149158.
  • Gustafsson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J., Lie, S.O., Moe, P.J., Perkkio, M., Yssing, M. & Saarinen-Pihkala, U.M. (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatrica, 87, 11511161.
  • Heerema, N.A., Maben, K.D., Bernstein, J., Breitfeld, P.P., Neiman, R.S. & Vance, G.H. (1996) Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients. Cancer Genetics and Cytogenetics, 92, 111115.
  • ISCN (2005) An International System for Human Cytogenetics Nomenclature (ed. by L.G.Shaffer & N.Tommerup). Karger, Basel.
  • Jarosova, M., Holzerova, M., Mihal, V., Lakoma, I., Divoky, V., Blazek, B., Pospisilova, D., Hajduch, M., Novak, Z., Dusek, L., Koptikova, J., Poulsen, T.S. & Indrak, K. (2003) Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genetics and Cytogenetics, 145, 161168.
  • Kawamata, N., Ogawa, S., Zimmermann, M., Niebuhr, B., Stocking, C., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., Miller, C.W., Harbott, J., Ludwig, W.D., Stanulla, M., Schrappe, M., Bartram, C.R. & Koeffler, H.P. (2008) Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proceedings of the National Academy of Sciences of the United States of America, 105, 1192111926.
  • Lönnerholm, G., Nordgren, A., Frost, B.M., Jonsson, O.G., Kanerva, J., Nygaard, R., Schmiegelow, K., Larsson, R. & Forestier, E. (2009) Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids. Leukemia, 23, 209212.
  • Möricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dördelmann, M., Löning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. & Schrappe, M. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 44774489.
  • Nebral, K., Denk, D., Attarbaschi, A., König, M., Mann, G., Haas, O.A. & Strehl, S. (2009) Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia, 23, 134143.
  • Pinheiro, J.P. & Boos, J. (2004) The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined? British Journal of Haematology, 125, 117127.
  • Raimondi, S.C., Zhou, Y., Mathew, S., Shurtleff, S.A., Sandlund, J.T., Rivera, G.K., Behm, F.G. & Pui, C.H. (2003) Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer, 98, 27152722.
  • Rieder, H., Schnittger, S., Bodenstein, H., Schwonzen, M., Wormann, B., Berkovic, D., Ludwig, W.D., Hoelzer, D. & Fonatsch, C. (1995) dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes, Chromosomes and Cancer, 13, 5461.
  • Schmiegelow, K. & Gustafsson, G. (2005) Acute lymphoblastic leukemia. In: Cancer in Children: Clinical Management, 5th edn (ed. by P.A.Voute, A.Barett, M.C.G.Stevens & H.N.Caron), pp. 138170. Oxford University press, New York.
  • Schoumans, J., Johansson, B., Corcoran, M., Kuchinskaya, E., Golovleva, I., Grander, D., Forestier, E., Staaf, J., Borg, A., Gustafsson, B., Blennow, E. & Nordgren, A. (2006) Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. British Journal of Haematology, 135, 492499.
  • Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., Kornhuber, B., Ritter, J., Welte, K., Gadner, H. & Riehm, H. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 95, 33103322.
  • Slater, R., Smit, E., Kroes, W., Bellomo, M.J., Muhlematter, D., Harbott, J., Behrendt, H., Hahlen, K., Veerman, A.J. & Hagemeijer, A. (1995) A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11). Leukemia, 9, 16131619.
  • Van Zutven, L.J., Van Drunen, E., De Bont, J.M., Wattel, M.M., Den Boer, M.L., Pieters, R., Hagemeijer, A., Slater, R.M. & Beverloo, H.B. (2005) CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia. Leukemia, 19, 12811284.